AI-Assisted TelerehabiLitAtion System (ATLAS) for Post-discharge Continuation of Rehabilitative Care

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-99
SponsorSingHealth Community Hospitals

About this trial

The study team proposes ATLAS (AI-Assisted TelerehabiLitAtion System) a two-part solution. The first-Rebee AI-assisted telerehabilitation device-assists in inpatient rehabilitation, and allows patients to continue with their physical rehabilitation when discharged and waiting for Day Rehabilitation Centre (DRC). The second-a structured programme to train and familiarise patients and caregivers to Rebee over patients' Community Hospital (CH) inpatient rehabilitation stay-adopts an evidence-based approach to increase uptake and adherence to Rebee.

Eligibility criteria

Qualifiers

Rehabilitation Diagnostic Group (RDG): Total Knee Replacement / Deconditioning

Age 60 and above

Speak English/Mandarin

Able to follow instructions, no cognitive impairment

Disqualifiers

Not under RDG: Total Knee Replacement / Deconditioning

Below 60 years old

Unable to speak English/Mandarin

Cognitive impaired, unable to follow instructions

Trial design

Treatments tested in this trial

  • Rebee

Treatment groups

450 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

SingHealth Community Hospitals

Lead sponsor

Rebee Health

Collaborator

Jurong Community Hospital

Collaborator